Literature DB >> 23805357

Normal vitamin D levels are associated with spontaneous hepatitis B surface antigen seroclearance.

Mahmud Mahamid1, William Nseir, Omar Abu Elhija, Shimon Shteingart, Ammad Mahamid, Mosab Smamra, Benjamin Koslowsky.   

Abstract

AIM: To investigate a possible association between serum vitamin D levels and spontaneous hepatitis B surface antigen (HBsAg) seroclearance.
METHODS: Fifty-three patients diagnosed with chronic inactive hepatitis B and spontaneous HBsAg seroclearance were followed up in two Israeli liver units between 2007 and 2012. This retrospective study reviewed medical charts of all the patients, extracting demographic, serological and vitamin D rates in the serum, as well as medical conditions and current medical therapy. Spontaneous HBsAg seroclearance was defined as the loss of serum HBsAg indefinitely. Vitamin D levels were compared to all patients who underwent spontaneous HBsAg seroclearance.
RESULTS: Out of the 53 patients who underwent hepatitis B antigen seroclearance, 44 patients (83%) had normal levels of 25-hydroxyvitamin vitamin D compared to 9 patients (17%) who had below normal levels. Multivariate analysis showed that age (> 35 years) OR = 1.7 (95%CI: 1.25-2.8, P = 0.05), serum vitamin D levels (> 20 ng/mL) OR = 2.6 (95%CI: 2.4-3.2, P = 0.02), hepatitis B e antigen negativity OR = 2.1 (95%CI: 2.2-3.1, P = 0.02), low viral load (hepatitis B virus DNA < 100 IU/mL) OR = 3 (95%CI: 2.6-4.2, P = 0.01) and duration of HBsAg seropositivity (> 8 years) OR = 1.6 (95%CI: 1.15-2.6, P = 0.04) were also associated with spontaneous HBsAg seroclearance.
CONCLUSION: We found a strong correlation between normal vitamin D levels and spontaneous HBsAg seroclearance.

Entities:  

Keywords:  Hepatitis B; Immune disease; Seroclearance; Viral load; Vitamin D

Year:  2013        PMID: 23805357      PMCID: PMC3692974          DOI: 10.4254/wjh.v5.i6.328

Source DB:  PubMed          Journal:  World J Hepatol


  21 in total

Review 1.  Vitamin D and immune function: autocrine, paracrine or endocrine?

Authors:  Martin Hewison
Journal:  Scand J Clin Lab Invest Suppl       Date:  2012

2.  Prevalence of thyroid autoantibodies in hepatitis C and hepatitis B infection in China.

Authors:  Rong Yang; Zhongyan Shan; Yushu Li; Chenling Fan; Chenyang Li; Weiping Teng
Journal:  Intern Med       Date:  2011-04-15       Impact factor: 1.271

Review 3.  A review of the health consequences of the vitamin D deficiency pandemic.

Authors:  Harald Dobnig
Journal:  J Neurol Sci       Date:  2011-09-22       Impact factor: 3.181

Review 4.  Immune-mediated myelitis associated with hepatitis virus infections.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neuroimmunol       Date:  2011-09-25       Impact factor: 3.478

5.  Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.

Authors:  Jessica Liu; Hwai-I Yang; Mei-Hsuan Lee; Sheng-Nan Lu; Chin-Lan Jen; Li-Yu Wang; San-Lin You; Uchenna H Iloeje; Chien-Jen Chen
Journal:  Gastroenterology       Date:  2010-04-29       Impact factor: 22.682

6.  Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy.

Authors:  Sukran Kose; Ayhan Gozaydin; Gulgun Akkoclu; Gulfem Ece
Journal:  J Infect Dev Ctries       Date:  2012-04-13       Impact factor: 0.968

Review 7.  Vitamin D supplementation for cystic fibrosis.

Authors:  Janet H Ferguson; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 8.  Vitamin D and the immune system: new perspectives on an old theme.

Authors:  Martin Hewison
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

Review 9.  Autoimmune manifestations in viral hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2012-07-28       Impact factor: 11.759

10.  The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.

Authors:  Ilan Ben-Zvi; Cynthia Aranow; Meggan Mackay; Anfisa Stanevsky; Diane L Kamen; L Manuela Marinescu; Christopher E Collins; Gary S Gilkeson; Betty Diamond; John A Hardin
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more
  5 in total

Review 1.  Vitamin D supplementation for chronic liver diseases in adults.

Authors:  Milica Bjelakovic; Dimitrinka Nikolova; Goran Bjelakovic; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2021-08-25

Review 2.  Vitamin D and the Liver-Correlation or Cause?

Authors:  Jeremy T Keane; Harendran Elangovan; Rebecca A Stokes; Jenny E Gunton
Journal:  Nutrients       Date:  2018-04-16       Impact factor: 5.717

3.  Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection.

Authors:  Soheil Tavakolpour; Shahnaz Sali; Latif Gachkar
Journal:  Hepat Mon       Date:  2016-01-16       Impact factor: 0.660

4.  The prevalence and severity of 25-(OH)-vitamin D insufficiency in HCV infected and in HBV infected patients: a prospective study.

Authors:  Aleksandra Berkan-Kawińska; Ewa Koślińska-Berkan; Anna Piekarska
Journal:  Clin Exp Hepatol       Date:  2015-04-30

Review 5.  Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes.

Authors:  Choongho Lee
Journal:  Nutrients       Date:  2020-03-30       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.